AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 140 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,399,000 | +103.4% | 951,675 | +0.8% | 0.00% | – |
| Q2 2022 | $7,080,000 | -29.0% | 944,000 | -13.9% | 0.00% | – |
| Q1 2022 | $9,973,000 | +31.3% | 1,095,898 | +1.3% | 0.00% | – |
| Q4 2021 | $7,596,000 | -30.6% | 1,082,013 | +12.7% | 0.00% | -100.0% |
| Q3 2021 | $10,944,000 | -31.1% | 959,960 | -3.2% | 0.00% | 0.0% |
| Q2 2021 | $15,882,000 | +6.4% | 992,007 | +18.7% | 0.00% | 0.0% |
| Q1 2021 | $14,930,000 | +13.2% | 835,459 | -14.4% | 0.00% | 0.0% |
| Q4 2020 | $13,184,000 | +11.7% | 975,893 | -2.7% | 0.00% | 0.0% |
| Q3 2020 | $11,800,000 | -29.0% | 1,002,518 | -11.0% | 0.00% | 0.0% |
| Q2 2020 | $16,624,000 | +4.4% | 1,126,256 | -4.5% | 0.00% | 0.0% |
| Q1 2020 | $15,922,000 | -45.6% | 1,179,431 | -2.7% | 0.00% | -50.0% |
| Q4 2019 | $29,294,000 | +39.2% | 1,211,983 | +10.7% | 0.00% | 0.0% |
| Q3 2019 | $21,050,000 | -27.1% | 1,095,231 | +12.1% | 0.00% | 0.0% |
| Q2 2019 | $28,860,000 | -29.6% | 976,635 | +13.1% | 0.00% | -33.3% |
| Q1 2019 | $41,005,000 | +27.1% | 863,270 | -3.4% | 0.00% | 0.0% |
| Q4 2018 | $32,259,000 | -40.6% | 893,614 | +1.2% | 0.00% | -25.0% |
| Q3 2018 | $54,341,000 | +6.8% | 882,898 | +17.2% | 0.00% | 0.0% |
| Q2 2018 | $50,873,000 | +21.1% | 753,091 | -2.7% | 0.00% | 0.0% |
| Q1 2018 | $42,004,000 | -12.5% | 774,294 | -3.6% | 0.00% | 0.0% |
| Q4 2017 | $47,984,000 | +24.2% | 803,008 | +1.1% | 0.00% | +33.3% |
| Q3 2017 | $38,621,000 | +4.8% | 794,614 | +13.3% | 0.00% | 0.0% |
| Q2 2017 | $36,865,000 | +13.5% | 701,525 | -2.0% | 0.00% | 0.0% |
| Q1 2017 | $32,476,000 | +4.6% | 716,122 | -12.7% | 0.00% | 0.0% |
| Q4 2016 | $31,059,000 | +37.3% | 820,644 | +36.9% | 0.00% | +50.0% |
| Q3 2016 | $22,626,000 | +116.5% | 599,498 | +0.9% | 0.00% | +100.0% |
| Q2 2016 | $10,453,000 | +42.7% | 593,978 | -1.4% | 0.00% | 0.0% |
| Q1 2016 | $7,325,000 | -50.5% | 602,355 | -0.9% | 0.00% | -50.0% |
| Q4 2015 | $14,796,000 | +196.2% | 607,607 | +115.6% | 0.00% | +100.0% |
| Q3 2015 | $4,996,000 | +33.0% | 281,779 | +32.4% | 0.00% | – |
| Q2 2015 | $3,756,000 | -85.8% | 212,852 | -74.8% | 0.00% | -100.0% |
| Q1 2015 | $26,476,000 | +601.9% | 844,766 | +553.7% | 0.00% | – |
| Q4 2014 | $3,772,000 | +51.7% | 129,232 | +7.4% | 0.00% | – |
| Q3 2014 | $2,487,000 | -7.5% | 120,342 | +10.7% | 0.00% | – |
| Q2 2014 | $2,690,000 | +30.0% | 108,711 | +11.3% | 0.00% | – |
| Q1 2014 | $2,070,000 | +74.5% | 97,680 | +47.9% | 0.00% | – |
| Q4 2013 | $1,186,000 | – | 66,056 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|